Biofilm Formation by Clinical Isolates of S. aureus and S. epidermidis in Prosthetic Joint Infection | CMAC

Biofilm Formation by Clinical Isolates of S. aureus and S. epidermidis in Prosthetic Joint Infection

Clinical Microbiology and Antimicrobial Chemotherapy. 2014; 16(2):149-156

​ Bozhkova S.A., Krasnova M.V., Polyakova E.M., Rukina A.N., Shabanova V.V.
prosthetic joint infection S. aureus S. epidermidis microbial biofilms MRSA MRSE
Section
Personal Experience
Type
Journal article
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 2014; 16(2):149-156

Objective.

Objectives. In vitro study of biofilm forming capacity of S. aureus and S. epidermidis strains, most common etiological agents of PJI following orthopedic surgeries, depending on source of strain, species of etiological agent and methicillin susceptibility.

Materials and Methods.

241 S. aureus and 153 S. epidermidis strains, isolated from the tissue biopsies, the join aspirates and removed orthopedic prosthesis in 2012 year from 321 patients with PJI were investigated. Antibiotic susceptibility was estimated according to EUCAST criteria, version 1.3. The biofilm forming capacity was tested according to Christensen’s method (1985). When OD≥0,2 strains were considered as strong biofilm forming strains. Statistical analysis was performed with Z-criterion tested.

Results.

40,9% of strains were found to be strong biofilm forming strains. The most strong biofilm forming capacity was shown for 60,9% of S. epidermidis strains and 43,3% of S. aureus strains isolated from removed prosthesis. The strains of both species, isolated from tissue biopsies and removed orthopedic implants (OI), possessed strong biofilm forming capacity more often than isolates from aspirates (p<0,05). MRSA amounted to 30,7% and MRSE — 77,8%. The percentage of strong biofilm forming strains was more among MRSE strains compared to MRSA strains (47,9 vs 31,1%; p<0,05). The percentage of MR strains, isolated from biological samples, was higher than one for strains from removed OI (p<0.01).

Conclusions.

Staphylococcus spp., etiological agents of PJI, in 40,9% causes possessed strong biofilm forming capacity. The strong forming biofilm strains and methicillin resistant strains were seen more often among S. epidermidis strains, but any correlation between these properties was not revealed. The strong biofilm forming capacity was more typical for S. epidermidis strains and also for strains from OI and tissue biopsies compared to isolates from aspirates irrespective of staphylococcus species.

  • 1. Lee K., Goodman S.B. Current state and future of joint replacements in the hip and knee. Expert Rev Med Devices 2008; 5:383-93.
  • 2. Phillips C.B., Barrett J.A., Losina E., et al. Incidence rates of dislocation, pulmonary embolism, and deep infection during the first six months after elective total hip replacement. J Bone Joint Surg Am 2003; 85-A(1):20-6.
  • 3. Lie S.A., Engesaeter L.B., Havelin L.I., Gjessing H.K., Vollset S.E. Dependency issues in survival analyses of 55,782 primary hip replacements from 47,355 patients. Stat Med 2004; 23:3227-40.
  • 4. Zimmerli W., Trampuz A., Biomaterials-associated infection: a perspective from the clinic. In: Biomaterials Associated Infection: Immunological Aspects and Antimicrobial Strategies; Moriarty T.F., Zaat S.A.J., Busscher H. eds.; Springer: NY, Heidelberg Dordrecht: London, ed. 2013; pp. 3-24.
  • 5. Raja A.F., Furqan A., Inshad A. Kh., et al. Antistaphylococcal and biofilm inhibitory activities of acetyl-11-keto-β-boswellic acid from Boswellia serrata. BMC Microbiology 2011; 11:1-9.
  • 6. de Haas C.J., Veldkamp K.E., Peschel A., et al. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J Exp Med 2004; 199:687-95.
  • 7. Jiang X., Pace J.L. Microbial Biofilms. In: Biofilms, Infection and Antimicrobial Therapy; Pace J.L., Rupp M., Finch R.G., eds.; Taylor & Francis Group: Boca Raton, FL, USA, 2006; p. 3-19.
  • 8. Lin M., Chang F., Hua M., Wu Y., Liu S. Inhibitory effects of 1,2,3,4,6-penta-O-Galloyl-β-d-glucopyranose on biofilm formation by Staphylococcus aureus. Antimicrob Agents Chemother 2011; 55:1021-7.
  • 9. Zimmerli W. Infection and musculoskeletal conditions: Prosthetic-joint-associated infections. Best Pract Res Clin Rheumatol 2006; 20:1045-63.
  • 10. Barberán J. Management of infections of osteoarticular prosthesis. Clin Microbiol Infect 2006; 12 (Suppl 3):93- 101.
  • 11. Brady R.A., Calhoun J.H., Leid J.G., Shirtliff M.E. Infections of orthopaedic implants and devices. In: Biofilms and Device-Related Infections. Shirtliff ME and Leid JG. eds.; Springer: NY, 2009; pp. 15-56.
  • 12. Trampuz A., Piper K.E., Jacobson M.J., et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 2007; 357:654-63.
  • 13. European committee on antimicrobial susceptibility testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 1.3, 2011. Available from: URL: http://www.eucast.org/antimicrobial_susceptibility_testing/previous_versions_of_tables/
  • 14. Christensen G.D., Simpson W.A., Younger J.J., et al. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 1985; 22:996-1006.
  • 15. Esteban J., Molina-Manso D., Spiliopoulou I., et al. Biofilm development by clinical isolates of Staphylococcus spp. from retrieved orthopedic prostheses Acta Orthopaedica 2010; 81(6):674-9.
  • 16. Сергиенко В.И., Бондарева И.Б. Математическая статистика в клинических исследованиях. М.: ГЭОТАР МЕДИЦИНА, 2000; C. 70-3.
  • 17. Божкова С.А., Тихилов Р.М., Краснова М.В. с соавт. Профиль резистентности возбудителей как основа выбора эффективного антибиотика при стафилококковых инфекциях протезированных суставов. КМАХ 2013; 15(2):115-23.
  • 18. Peel T.N., Cheng A.C., Buising K.L., Choonga P.F. Microbiological aetiology, epidemiology, and clinical profile of prosthetic joint infections: are current antibiotic prophylaxis guidelines effective? Antimicrob Agents Chemother 2012; 56:2386-91.
  • 19. Сидоренко С.В. Микробиологические аспекты хирургических инфекций. Инфекции в хирургии 2003; (1):22-7.
  • 20. Fey P.D., Olson M.E. Current concepts in biofilm formation of Staphylococcus epidermidis. Future Microbiol 2010; 5:917-33.
  • 21. Schoenfelder S.M., Lange C., Eckart M., et al. Success through diversity – how Staphylococcus epidermidis establishes as a nosocomial pathogen. Int J Med Microbiol 2010; 300:380-6.
  • 22. Ziebuhr W., Hennig S., Eckart M., et al. Nosocomial infections by Staphylococcus epidermidis: how a commensal bacterium turns into a pathogen. Int J Antimicrob Agents 2006; 28 (Suppl 1):14-20.
  • 23. Arciola C.R., Campoccia D., Gamberini S., et al. Antibiotic resistance in exopolysaccharide-forming Staphylococcus epidermidis clinical isolates from orthopaedic implant infections. Biomaterials 2005; 26:6530-5.
  • 24. Otto M. Staphylococcal biofilms. Curr Top Microbiol Immunol 2008; 322:207-28.
  • 25. Bloemendaal A.L.A., Brouwer E.C., Fluit A.C. Methicillin resistance transfer from Staphylococcus epidermidis to methicillin-susceptible Staphylococcus aureus in a patient during antibiotic therapy. PLoS ONE 2010; 5(7):e11841.
  • 26. Otto M. Coagulase-negative staphylococci as reservoirs of genes facilitating MRSA infection: Staphylococcal commensal species such as Staphylococcus epidermidis are being recognized as important sources of genes promoting MRSA colonization and virulence. BioEssays: news and reviews in molecular, cellular and developmental biology 2013; 35:4-11.
  • 27. O’Gara J.P., Humphreys H. Staphylococcus epidermidis biofilms: importance and implications. J Med Microbiol 2001; 50:582-7.
  • 28. McCann M.T., Gilmore B.F., Gorman S.P. Staphylococcus epidermidis device-related infections: pathogenesis and clinical management. JPP 2008; 60:1551-71.
  • 29. Fitzpatrick F., Humphreys H., Smyth E.G., et al. Environmental regulation of biofilm formation in intensive care unit isolates of Staphylococcus epidermidis. J hospital infection 2002; 52:212-8.
  • 30. Smith K., Perez A., Ramage G., et al. Biofilm formation by Scottish clinical isolates of Staphylococcus aureus. J Med Microbiol 2008; 57:1018-23.
Views
0 Abstract
0 PDF
0 Crossref citations
Shared